Jeffry D Shearer

Summary

Affiliation: DynPort Vaccine Company LLC
Country: USA

Publications

  1. doi Preclinical safety assessment of recombinant botulinum vaccine A/B (rBV A/B)
    Jeffry D Shearer
    DynPort Vaccine Company LLC, A CSC Company, Frederick, MD 21702, USA
    Vaccine 30:1917-26. 2012
  2. pmc Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection
    Jeffry D Shearer
    DVC LLC, 64 Thomas Johnson Drive, Frederick, Maryland 21702, USA
    Antimicrob Agents Chemother 49:2634-41. 2005
  3. doi Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B)
    Jeffry D Shearer
    DynPort Vaccine Company LLC, A CSC Company, 64 Thomas Johnson Drive, Frederick, MD 21702, USA
    Vaccine 28:7313-8. 2010
  4. ncbi Preclinical safety assessment of a recombinant plague vaccine (rF1V)
    Jessica L Price
    DynPort Vaccine Company LLC, A CSC Company, 64 Thomas Johnson Drive Frederick, MD 21702, USA Email
    Int J Toxicol 32:327-35. 2013

Collaborators

Detail Information

Publications4

  1. doi Preclinical safety assessment of recombinant botulinum vaccine A/B (rBV A/B)
    Jeffry D Shearer
    DynPort Vaccine Company LLC, A CSC Company, Frederick, MD 21702, USA
    Vaccine 30:1917-26. 2012
    ..Together these results indicated a favorable safety profile for rBV A/B and supported its use in a Phase 1 clinical trial...
  2. pmc Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection
    Jeffry D Shearer
    DVC LLC, 64 Thomas Johnson Drive, Frederick, Maryland 21702, USA
    Antimicrob Agents Chemother 49:2634-41. 2005
    ..The timing of treatment relative to VV inoculation appeared to be important for the demonstration of VIGIV's biological activity...
  3. doi Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B)
    Jeffry D Shearer
    DynPort Vaccine Company LLC, A CSC Company, 64 Thomas Johnson Drive, Frederick, MD 21702, USA
    Vaccine 28:7313-8. 2010
    ..Additionally, estimates of the neutralizing efficiency have been established for BoNT/A1 and BoNT/B1 neutralizing antibodies obtained from clinical volunteers vaccinated with the rBV A/B...
  4. ncbi Preclinical safety assessment of a recombinant plague vaccine (rF1V)
    Jessica L Price
    DynPort Vaccine Company LLC, A CSC Company, 64 Thomas Johnson Drive Frederick, MD 21702, USA Email
    Int J Toxicol 32:327-35. 2013
    ..The rF1V vaccine produced no apparent systemic toxicity and only transient edema and erythema at the injection site. Together these results indicated a favorable safety profile for rF1V and supported its use in a Phase 1 clinical trial. ..